Interpace Biosciences Inc IDXG
$1.52 $0.09 (5.42%) 1D
Last Updated: Aug 21, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
IDXG Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Interpace Biosciences Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Interpace Biosciences Inc. Stock Analysis IDXG
United States Health Care Nano Cap Interpace Biosciences, Inc. engages in the development and sale of diagnostic clinical and pharma services. The company is headquartered in Parsippany, New Jersey and currently employs 102 full-time employees. The Company’s clinical services business commercializes clinically useful molecular diagnostic tests and molecular pathology services. The firm develops and commercializes genomic tests and related first-line assays that can personalize medicine to help improve patient diagnosis and management. The company has five commercialized molecular diagnostic tests: PancraGEN, PanDNA, ThyGeNEXT, ThyraMIR v2, and RespriDX. PancraGEN is a pancreatic cyst and pancreaticobiliary solid lesion genomic test that helps physicians’ better risk-stratify pancreaticobiliary cancers using the Company’s proprietary PathFinderTG platform. PanDNA is an alternate reporting option of the PathFinderTG platform, which provides physicians the molecular only information. ThyGeNEXT is an oncogenic mutation panel that helps rule-in and rule-out malignancy in thyroid nodules.
Interpace Biosciences Inc (IDXG) Chart
Financial Metrics & Statements of Interpace Biosciences Inc (IDXG)
FAQ's for Interpace Biosciences Inc (IDXG)
- As of August 2026, Interpace Biosciences Inc IDXG is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Interpace Biosciences Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Interpace Biosciences Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Interpace Biosciences Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Interpace Biosciences Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Interpace Biosciences Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Interpace Biosciences Inc (IDXG)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
